
Article 1 
Australia and New Zealand are granted temporary access to the Community reserves of antigens for the formulation of vaccines against foot-and-mouth disease under the following conditions:

1.. access shall be granted until 31 December 2005, in the form of drawing rights for each of the two countries concerned for a maximum of 500 000 vaccine equivalent cattle doses and in any case for both countries together not more than 50 % of the existing stocks of each of the antigens in the Community reserves;
2.. depending on the specification in the written request by the competent authorities of Australia or New Zealand, the Commission shall immediately arrange for the urgent or immediate formulation of the appropriate antigens and the production, bottling, labelling and delivery of the vaccines under the terms of existing contracts concluded between itself and the manufacturer;
3.. the Commission shall make arrangements so as to ensure that in the event referred to in paragraph 2 the costs for the following actions are born in appropriate proportions by the competent authorities of Australia or New Zealand, whoever has requested the formulation into vaccines of antigens stored in the Community reserves:

((a)) the transfer of antigens from the place of storage to the establishment of the manufacturer;
((b)) the formulation and production of vaccines, including any additional testing that might prove necessary;
((c)) the bottling and labelling of the vaccines and their transport to the indicated place of delivery;
((d)) the replacement without delay of any used quantity of antigen by antigens of at least the same quality and origin.
Article 2 
This Decision is addressed to the Member States.